Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000070858-26-000529·IRONWOOD PHARMACEUTICALS INC
Schedule 13G ownership disclosure
Ironwood Pharmaceuticals Inc
Class A Common Stock · CUSIP: 46333X108
Event date: 2026-09-30
- Filing-level shares
- 5,219,315.00
- Percent of class
- 3.2%
- BANK OF AMERICA CORP /DE/
Shares: 5,219,315.00 · Class: 3.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000070858-26-000529
- Form type
- SCHEDULE 13G/A
- Filer
- IRONWOOD PHARMACEUTICALS INC
- CIK
- CIK 1446847
- Filed
- Oct 28, 2026
- Reporting period
- Sep 30, 2026
- Description
- Schedule 13G beneficial ownership